Vitamin D Insufficiency Increases Fall Risk in Older Patients With Cancer

A new study suggests some older cancer patients are at an increased risk of injury-causing falls.
BY KATIE KOSKO @Katie_Kosko
PUBLISHED: MARCH 03, 2017
Aging comes with a wide range of health challenges, including muscle loss and the risk of falls. When you add a cancer diagnosis to the mix, those challenges increase. However, there are ways that patients with cancer can reduce their risk.

In a recent study presented at the 2017 Cancer Survivorship Symposium, researchers from MD Anderson Cancer Center in Houston examined the prevalence of vitamin D insufficiency and risk factors for falls in patients aged 65 or older undergoing active cancer care for gastrointestinal, urologic, breast, lung or gynecologic cancers.

They found that these patients were more likely to experience frailty, osteoporosis and vitamin D insufficiency, raising the possibility of injury-causing falls.

“Sixty percent of patients with cancer are over the age of 65, and that number is going to grow,” Beatrice J. Edwards, M.D., M.P.H., F.A.C.P., associate professor geriatric medicine and author on the study, said in an interview with CURE. “These unique issues that they present have to be addressed in order to give them the best quality of life possible.”

The study was conducted by giving 305 patients, both men and women, a comprehensive geriatric assessment, including cognitive, functional, nutritional, physical and comorbidity assessment. Researchers also examined bone density and vitamin D.

Eighty percent of patients had low bone mass and osteoporosis; 53 percent experienced frailty; 48.8 percent had vitamin D insufficiency; 37 percent experienced mild cognitive impairment; and 33 percent had dementia.


Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
x-button
Special Feature
Share Your Art
Related Articles
The Logistics of Multigene Panel Testing in Breast Cancer
Generally, health insurance covers the cost of genetic testing recommended by a physician. However, some patients who had BRCA testing in the past have had trouble getting reimbursed for a follow-up panel test. The outof- pocket cost for a single panel test can be up to $5,000, although lower-cost tests are available.
Young Patients With Cancer Don't Always Get the Info They Need
When treated for cancer, young patients don’t always get the information they need from doctors.
Immunotherapy Offers New Optimism for Patients With Merkel Cell Carcinoma
Although chemotherapy has been used to treat patients with Merkel cell carcinoma, immunotherapy agents show great promise, according to findings presented at the 2017 World Congress of Melanoma.
Related Videos
Preserving Eyebrows During Chemotherapy Treatment
Renata Marie Vestevich, founder and developer of Essential Eyebrow Solution (EES), discusses how this topical solution may be able to help patients keep their eyebrow hair while undergoing chemotherapy.
Does Age Affect Cancer Genomics?
Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.  
Facing Advanced Cancer's Struggles With CALM
Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.
x
//For side ad protocol